Cinacalcet for the treatment of secondary hyperparathyroidism (HPT) in patients non responsive to vitamin D

被引：0
|
作者：
Malberti, Fabio
Villa, Giuseppe
Colussi, Giacomo
Mingardi, Giulio
Quartagno, Rita
Limido, Aurelio
Conte, Ferruccio
Farina, Marco
Montagna, G.
Vezzoli, Giuseppe
Ravani, Pietro
机构：
[1] Ist Ospitalieri, Div Nefrol, Cremona, Italy
[2] Fdn Maugeri, Div Nefrol, Pavia, Italy
[3] Fdn Macchi, Div Nefrol, Varese, Italy
[4] Osped Riuniti Bergamo, Div Nephrol, I-24100 Bergamo, Italy
[5] IRCCS San Raffaele, Div Nefrol, Milan, Italy
[6] Osped Causa Pia Uboldo, Div Nefrol, Cernusco Sul Naviglio, Italy
[7] Osped S Antonio Abate, Div Nefrol, Gallarate, Italy
[8] Osped Maggiore Lodi, Div Nefrol, Lodi, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [41] Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Wiecek, Andrzej
    BMC NEPHROLOGY, 2016, 17 : 1 - 7
  • [42] Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis
    Charytan, C
    Coburn, JW
    Chonchol, M
    Herman, J
    Lien, YH
    Liu, W
    Klassen, PS
    McCary, LC
    Pichette, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) : 58 - 67
  • [43] Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
    Piotr Kuczera
    Marcin Adamczak
    Andrzej Więcek
    BMC Nephrology, 17
  • [44] Oral cinacalcet HCI (AMG 073) for the treatment of hemodialysis patients with secondary hyperparathyroidism (HPT): Results of a European/Australian-Phase 3 study.
    de Francisco, ALM
    Suranyi, M
    Cunningham, J
    Messa, P
    Locatelli, F
    Evenepoel, P
    Fournier, A
    Gonzalez, MT
    Urena, P
    Holzer, H
    Brink, HS
    Johnson, D
    Zani, V
    Baker, N
    Turner, SA
    Drueke, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 461A - 461A
  • [45] Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism
    Denis Wirowski
    Peter E. Goretzki
    Katharina Schwarz
    Bernhard J. Lammers
    Langenbeck's Archives of Surgery, 2013, 398 : 131 - 138
  • [46] Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
    Jeong, Sohyun
    Kim, In-Wha
    Oh, Kook-Hwan
    Han, Nayoung
    Joo, Kwon Wook
    Kim, Hyo Jin
    Oh, Jung Mi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2211 - 2224
  • [47] Achievement of proposed NKF-K/DOQI bone metabolism and disease targets: Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism (HPT)
    Moe, SM
    Coburn, JW
    Quarles, LD
    Goodman, WG
    Chertow, GM
    Block, GA
    Drueke, T
    Cunningham, J
    Sherrard, DJ
    McCary, LC
    Olson, KA
    Turner, SA
    Martin, KJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 48A - 48A
  • [48] Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism
    Wirowski, Denis
    Goretzki, Peter E.
    Schwarz, Katharina
    Lammers, Bernhard J.
    LANGENBECKS ARCHIVES OF SURGERY, 2013, 398 (01) : 131 - 138
  • [49] THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Choi, Bum Soon
    Choi, Sun Ryoung
    Park, Hoon Suk
    Hong, Yu Ah
    Chung, Byung Ha
    Kim, Young Soo
    Yang, Chul Woo
    Kim, Yong-Soo
    Park, Cheol Whee
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 442 - 442
  • [50] Cinacalcet Hydrochloride Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
    El-Shafey, Eid M.
    Alsahow, Ali E.
    Alsaran, Khalid
    Sabry, Alaa A.
    Atia, Mohamed
    THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 (06) : 547 - 555
12345